Merck KGaA

Merck KGaA

Organization

Heard in 8 episodes across 6 shows since Jun 2026

Merck KGaA is a German multinational science and technology company headquartered in Darmstadt, operating in healthcare, life science, and electronics. In the podcast references, it is the German pharmaceutical company associated with Keytruda comparisons and the announced approximately $1 billion cash acquisition of Silence Therapeutics; it is distinct from the U.S. company Merck & Co. (known as MSD outside the United States).

Discussed inMarkets100%

Episodes

8
across 6 shows

This week

0
episodes on 0 shows

Expert statements

1
1 positive

Share of the conversation

Mentions of Merck KGaA per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.

0.0‰0.02‰0.04‰0.06‰Aug 25Sep 16Oct 9Oct 31Nov 22
Show the data
DayShare (7-day)Mentions
Oct 190.01‰1
Oct 200.04‰4
Oct 230.05‰1
Oct 260.05‰1
Nov 160.01‰1

The full trend: rank, tone and why it is trending →

Email alert

Email me when Merck KGaA comes up on a podcast

One email a week at most, with the new episodes that mention Merck KGaA. Free, no account needed, unsubscribe in one click.

What experts have said about Merck KGaA

1 statement · 1 positive

  1. Dan CurtisPositiveJun 25, 2026· Stock Movers

    Merck KGaA is buying Biotechny for $73 per share in cash.

    “Merck K gaa, that's the one based in Germany, is buying the global life science company for $73 a share in cash.”

    Listen at 3:10

    Open the episode · Micron Surges; Alibaba Lower; Wendy's Soars

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

8 episodes featuring Merck KGaA, newest first